Skip to content
Disclosery

Lepercq De Neuflize Asset Management LLC

Follow

13F filer, CIK 1854423, NEW YORK, NY

Lepercq De Neuflize Asset Management LLC reported $151,585,875 across 10 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-11.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-001824

Period
2025-06-30
Reported value
$152M
Holdings
10
Top 10 weight
100%
New
3
Sold out
7

Largest buys vs the previous quarter

SecurityShares changeApprox. value
QRVOnew+13,700$1.16M
SQFTnew+14,412$75.4K
CLARadded+10,000$34.7K
LAVA THERAPEUTICS NVadded+8,000$10.6K
WETHadded+10,000$9.5K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LFCRexited-19,700-$139K
PRESIDIO PPTY TR INCexited-134,125-$77.1K
Enzo Biochem Incexited-156,303-$57.8K
ANTXexited-23,234-$31.6K
BRNexited-15,000-$24.3K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001420506-25-001824, largest first. % of portfolio is the value over $114,514,875, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 115,245 shares; 2025Q1: 115,245 shares; 2025Q2: 115,245 shares 115,245$71.2M62.18%0Timeline
EFAISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 466,000 shares; 2025Q1: 466,000 shares; 2025Q2: 466,000 shares 466,000$41.7M36.38%0Timeline
QRVOQORVO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 13,700 shares 13,700$1.16M1.02%newTimeline
XYLO TECHNOLOGIES LTD - SPO…XYLO TECHNOLOGIES LTD - SPON ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 26,059 shares; 2025Q1: 26,059 shares; 2025Q2: 26,059 shares 26,059$132K0.12%0
CLARCLARUS CORP NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 21,000 shares; 2025Q1: 22,200 shares; 2025Q2: 32,200 shares 32,200$112K0.1%+10,000Timeline
SQFTPRESIDIO PPTY TR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,412 shares 14,412$75.4K0.07%newTimeline
WETHWETOUCH TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 67,954 shares; 2025Q1: 67,954 shares; 2025Q2: 77,954 shares 77,954$74K0.06%+10,000Timeline
ESSA PHARMA INCESSA PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 30,200 shares; 2025Q1: 31,700 shares; 2025Q2: 33,700 shares 33,700$57.3K0.05%+2,000
LAVA THERAPEUTICS NVLAVA THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 23,000 shares; 2025Q2: 31,000 shares 31,000$40.9K0.04%+8,000

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T PUTput60,000$37.1Mnew

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LFCRLIFECORE BIOMEDICAL INC19,700$139Kshares
PRESIDIO PPTY TR INCPRESIDIO PPTY TR INC134,125$77.1Kshares
Enzo Biochem IncEnzo Biochem Inc156,303$57.8Kshares
ANTXAN2 THERAPEUTICS INC23,234$31.6Kshares
BRNBARNWELL INDS INC15,000$24.3Kshares
DSWLDESWELL INDS INC10,000$23.6Kshares
LGL GROUP INCLGL GROUP INC26,200$8.38Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-001824 base2025-08-11acceptance time not in the bulk data set